CHRONIC PAIN REFERENCES

1. Dicebat Bernardus Carnotensis nos esse quasi nanos, gigantium humeris insidentes, ut possimus plura eis et remotiora videre, non utique proprii visus acumine, aut eminentia corporis, sed quia in altum subvenimur et extollimur magnitudine gigantea translated from Latin to English Bernard of Chartres used to say that we are like dwarfs on the shoulders of giants, so that we can see more than they, and things at a greater distance, not by virtue of any sharpness of sight on our part, or any physical distinction, but because we are carried high and raised up by their giant size. John of Salisbury, (1120–1180) in Metalogicon (1159).

2. A dwarf standing on the shoulders of a giant may see farther than a giant himself. Robert Burton (1577–1640) in The Anatomy of Melancholy (1621–1651).

3. Deyo RA, Walsh NE, Martin DC, et al. A controlled trial of transcutaneous electrical nerve stimulation (TENS) and exercise for chronic low back pain. N Engl J Med. 1990;322:1627–1634.

4. Merskey H. Classification of chronic pain—descriptions of chronic pain syndromes and definitions of pain terms. Pain. 1986;3(suppl): 1–225.

5. Merskey H, Bugduk N. Classification of Chronic Pain—Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd ed. Seattle: IASP Press; 1994.

6. Geertzen JHB, Van Wilgen CP, Schrier E, et al. Chronic pain in rehabilitation medicine. Disabil Rehabil. 2006;28(6):363–367.

7. Crook J. The prevalence of pain complaints in a general population. Pain. 1984;18:299–314.

8. Bonica JJ, Loeser JD. History of pain concepts and therapies. In: Loeser JD, ed. Bonica’s Management of Pain. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001:3–16.

9. MacFarlane GJ, Jones GT, McBeth J. Epidemiology of Pain. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack’s Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2006:1199–1214.

10. World Health Organization/Bone and Joint Decade. The Burden of Musculoskeletal Disease in a New Millennium. Geneva: World Health Organization; 2002.

11. Jacobs JP, Gnatz SM, Lane N, et al. The Burden of Musculoskeletal Disease in the United States. Rosemont: American Academy of Orthopedic Surgery; 2008.

12. Fitzgibbon DR, Chapman CR. Cancer pain: assessment and diagnosis. In: Loeser JD, ed. Bonica’s Management of Pain. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001:623–658.

13. Foley KM. The treatment of cancer pain. N Engl J Med. 1985; 313:84–95.

14. Twycross RG, Lack SA. Symptom Control and Far Advanced Cancer: Pain Relief. London: Pitman; 1984.

15. Cailliet R. Disuse syndrome—fibrocystic and degenerative changes. In: Brena SF, Chapman SL, eds. Management of Patients with Chronic Pain. New York: Sectrum; 1983:63–71.

16. Browse NL. The Physiology and Pathology of Bed Rest. Springfield, IL: Charles C. Thomas; 1965:1–221.

17. Granger C, ed. Functional Assessment in Rehabilitation. Baltimore: Williams & Wilkins; 1984.

18. Powers JH. The abuse of rest as a therapeutic measure in surgery. JAMA.125;1079:1944.

19. Snow BR, Pinter I, Gusmorino P, et al. Incidence of physical and psychosocial disabilities in chronic pain patients: initial report. Bull Hosp Jt Dis Orthop Inst. 1986;46:22–30.

20. Guck TP, Meilman PW, Skultety FM, et al. Prediction of long-term outcome of multidisciplinary pain treatment. Arch Phys Med Rehabil. 1986;67:293–296.

21. Arnstein PM. The neuroplastic phenomenon: a physiologic link between chronic pain and learning. J Neurosci Nurs. 1997;29:179–186.

22. Wilkins KL, McGrath PJ, Finley GA, et al. Phantom limb sensations and phantom limb pain in child and adolescent amputees. Pain.1998;78:7–12.

23. Kalso E. Memory for pain. Acta Anaesthesiol Scand. 1997;41(S110): 129–130.

24. Villemure C, Bushnell MC. Cognitive modulation of pain: how do attention and emotion influence pain processing? Pain. 2002;95: 195–199.

25. Tasmuth T, Estlanderb AM, Kalso E. Effect of present pain and mood on the memory of past postoperative pain in women treated surgically for breast cancer. Pain. 1996;68:343–347.

26. Chaplin ER. Chronic pain: a sociobiological problem. Phys Med Rehabil Stars. 1991;5:1–48.

27. Bishop B. Pain: its physiology and rationale for management. Part I. Neuroanatomical substrate for pain. Phys Ther. 1980;60:13–37.

28. Terman GW, Bonica JJ. Spinal mechanisms and their modulation. In: Loeser JD, ed. Bonica’s Management of Pain. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001:73–152.

29. Edmeads J. The physiology of pain: a review. Prog Neuropsychopharmacol Biol Psychiatry. 1983;7:413–419.

30. Zimmerman M. The somatovisceral sensory system. In: Schmidt RF, Thews G, eds. Human Physiology. 3rd ed. New York: Springer-Verlag; 1989:224–233.

31. Schmidt RE. Nociception and pain. In: Schmidt RF, Thews G, eds. Human Physiology. 3rd ed. New York: Springer-Verlag; 1989:223–236.

32. Basbaum AI, Fields HL. Endogenous pain control mechanisms— brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci.1984;7:309–338.

33. Kruger L, Mantyh P. Changing concepts in the anatomy of pain. Semin Anesth. 1985;4:209–217.

34. Liebeskind J, Sherman J, Cannon JT, et al. Neural and neurochemical mechanisms of pain inhibition. Semin Anesth. 1985;4:218–222.

35. Snyder SH. Opiate receptors and internal opiates. Sci Am. 1977; 236:44–56.

36. Melzack R, Wall PD. Pain mechanisms: a new theory. Science.1965;150:971–977.

37. Jessell TM, Kelly DD. Pain and analgesia. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of Neural Science. 3rd ed. New York: Elsevier/ North Holland; 1991:385–399.

38. Wall PD. Comments after 30 years of the gate control theory. Pain Forum. 1996;5:12–22.

39. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765–1768.

40. Sjolund BH, Eriksson MBE. Endorphins and analgesia produced by peripheral conditioning stimulation. In: Bonica JJ, Abe-Fessard D, Liebeskind JC, eds. Advances in Pain Research and Therapy. 3rd ed. New York: Raven; 1979:587–599.

41. Morely GK, Erickson DL, Morley JE. The neurology of pain. In: Baker AB, Joynt RJ, eds. Clinical Neurology. Philadelphia, PA: Harper & Row; 1996:1–95.

42. Watkins LR, Mayer DJ. Organization of endogenous opiate and nonopiate pain control systems. Science. 1982;216:11–85.

43. Coderre TJ, Katz J, Vaccarino AL, et al. Contribution of central neural plasticity to pathological pain: review of clinical and experimental evidence. Pain. 1993;52:259–285.

44. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med.2003;349:1943.

45. Yu C, Garry M, Zollo R, et al. Novel targets in gene therapy and the management of pain, part I: strategies and methods. Anesthesiology.2001;94:1119–1132.

46. Wu C, Garry M, Zollo R, et al. Novel targets in gene therapy and the management of pain, part II: molecular targets. Anesthesiology.2001;95:216–240.

47. Mogil JS, Wu L, Basbaum AI. Pain genes? Natural variation and transgenic mutants. Annu Rev Neurosci. 2000;23:777–811.

48. Bengtsson B, Thorson J. Back pain: a study of twins. Acta Genet Med Gemmellol (Roma). 1991;40:83–90.

49. Buskila D, Neumann L, Hazanov I, et al. Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum. 1996;26:605–611.

50. Treloar SA, Martin NG, Heath AC. Longitudinal genetic analysis of menstrual flow, pain, and limitation in a sample of Australian twins. Behav Genet. 1998;28:107–116.

51. Peroutka SJ. Genetic basis of migraine. Clin Neurosci. 1998;5:34–37.

52. Mogil JS. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci USA. 1999;96:7744– 7751.

53. Turk DC, Flor H, Rudy TE. Pain and families. I. Etiology, maintenance, and psychosocial impact. Pain. 1987;30:3–27.

54. Indo Y, Tsurata Y, Karim MA, et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhydrosis. Nat Genet. 1996;13:485–488.

55. Meyer UA. The molecular basis of genetic polymorphisms of drug metabolism. J Pharm Pharmacol. 1994;46:409–415.

56. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNLIA4. Cell. 1996;87:543–552.

57. Offenbaecher M, Bondy B, de Jonge S, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 1999;42:2482–2488.

58. Kemler MA, van de Vusse AC, van den Berg-Loonen EM, et al. HLA-DQ1 associated with reflex sympathetic dystrophy. Neurology.

1999;53:1350–1351.

59. Lazorthes Y, Sagen J, Sallerin B, et al. Human chromaffin cell graphed (CFF) for cancer pain management: a prospective phase two clinical study. Pain. 2000;87:19–32.

60. Ladarola MJ, Lee S, Mannes AJ. Gene transfer approach to pain control. In: Borsook, ed. Molecular Neurobiology of Pain. Seattle: IASP Press; 1997:337–360.

61. Houde RW. The use and misuse of opioids in the treatment of chronic pain. Adv Neurol. 1974;4:527–536.

62. Sharap AD. The knowledge, attitudes, and experience of medical personnel treating pain in the terminally ill. Mt Sinai J Med. 1978;45: 561–580.

63. Andrews IC. Management of postoperative pain. Int Anesthesiol Clin.1983;21:31–42.

64. Torda TA. Management of acute and post-operative pain. Int Anesthesiol Clin. 1983;21:27–47.

65. Weinstein SM, Herring SA, Shelton JL. The injured worker: assessment and treatment. Phys Med Rehabil Stars. 1990;4:361–377.

66. Waddell G. Biopsychosocial analysis of low back pain. Baillieres Clin Rheumatol. 1992;6:523–557.

67. Bigos SJ, Battie MC, Spengler DM, et al. Prospective study on work perceptions and psychosocial factors affecting report of back injury. Spine. 1991;16:1–6.

68. Skovron ML, Szpalski M, Nordin M, et al. Social cultural factors in back pain: the population based in Belgium adults. Spine. 1994;19: 129–137.

69. Fordyce WE. Learned pain: pain as a behavior. In: Loeser JD, ed. Bonica’s Management of Pain. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001:478–482.

70. Fordyce W, McMahon R, Rainwater G. Pain complaint—exercise performance, relationship and chronic pain. Pain. 1981;10:311–321.

71. Macfarlane GJ, Norrie G, Atherton K, et al. The influence of socioeconomic status on the reporting of regional and widespread musculoskeletal pain: results from the 1958 British Birth Cohort Study. Ann Rheum Dis. 2009;68(10):1591–1595.

72. Behan RC, Hirschfeld AH. The accident process—toward more rational treatment of industrial injuries. JAMA. 1963;186:300–306.

73. Rohling ML, Binder LM, Langhinrichsen-Rohling J. Money matters: a meta-analytic review of the association between financial compensation and the experience and treatment of chronic pain. Health Psychol.1995;14:537–547.

74. Beals RK. Compensation and recovery from injury. West J Med.1984;140:233–237.

75. Walsh NE, Dumitru D. Compensation in low back pain. Phys Med Rehabil Stars. 1991;5:223–236.

76. Seres JS, Newman RI. Negative influence of the disability compensation system—perspectives for the clinician. Semin Neurol. 1983;3: 360–369.

77. Aronoff GM, Dupuy DN. Evaluation and management of back pain: preventing disability. In: Aronoff GM, ed. Evaluation and Treatment of Chronic Pain. 3rd ed. Baltimore: Williams & Wilkins; 1998:247–257.

78. Steinberg FU. The Immobilized Patient—Functional Pathology and Management. New York: Plenum; 1980.

79. Portnow JM, Strassman HD. Medically induced drug addiction. Int J Addict. 1985;20:605–611.

80. Stimmel B. Pain, analgesia, and addiction: an approach to the pharmacologic management of pain. Clin J Pain. 1985;1:14–22.

81. Halpern L. Substitution-detoxification and its role in the management of chronic benign pain. J Clin Psychiatry. 1982;43:10–14.

82. O’Brien CP. Drug addiction and drug abuse. In: Hardman JG, Goodman Gilman A, Limbird LE, eds. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 1996:557–577.

83. Kleeland CS, Kleeland LM, Dar R, et al. Factors influencing physician management of cancer pain. Cancer. 1986;58:796–800.

84. Du Pen SL, Du Pen A, Polissar N, et al. Implementing guidelines for cancer pain management: results of a randomized controlled clinical trials. J Clinl Oncol. 1999;17:361–370.

85. Cherny NI, Ho MN, Bookbinder M, et al. Cancer pain knowledge and attitudes of physicians at a cancer center. Proc ASCO. 1994;13: 434–438.

86. Maruta T, Swanson DW, Finlayson RE. Drug abuse and dependency in patients with chronic pain. Mayo Clin Proc. 1979;54:241–244.

87. Finlayson RE, Maruta T, Morse RM. Substance dependence and chronic pain: experience with treatment and follow-up results. Pain.1986;26:175–180.

88. Fordyce WE. Behavioral Methods for Chronic Pain and Illness. St. Louis: CV Mosby; 1976:41–221.

89. Rowat KM, Knafl KA. Living with chronic pain: the spouse’s perspective. Pain. 1985;23:259–271.

90. Infante M. Sexual dysfunction in the patient with chronic back pain. Sex Disabil. 1981;4:173–178.

91. Ahern D, Adams AE, Follick MJ. Emotional and marital disturbances in spouses of chronic low back pain patients. Clin J Pain.1985;1:69–74.

92. Benca RM, Ancoli-Israel S, Moldofsky H. Special considerations in insomnia diagnosis and management: depressed, elderly, and chronic pain populations. J Clin Psychiatry. 2004;65(suppl 8):26–35.

93. Jacobson L, Mariano AJ. General considerations of chronic pain. In: Loeser JD, ed. Bonica’s Management of Pain. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001:241–254.

94. Brena SF, Chapman SL, Decker R. Chronic pain as a learned experience. In: Ng LKY, ed. New Approaches to Treatment of Chronic Pain. Washington, DC: U.S. Department of Health and Human Services; 1981:76–83.

95. Kerr AT. The brachial plexus of nerves in man, the variations in its formation, and branches. Am J Anat. 1918;23:285–395.

96. Foerster O. Dermatomes in man. Brain. 1933;56:1–39.

97. Bing R. In: Haymaker W, ed., transl, ed. Compendium of Regional Diagnosis in the Lesions of the Brain and Spinal Cord. 11th ed. St. Louis: CV Mosby; 1940.

98. Haymaker W, Woodhall B. Peripheral Nerve Injuries—Principles of Diagnosis. 2nd ed. Philadelphia, PA: WB Saunders; 1953.

99. Keagan JJ, Garrett FD. The segmental distribution of the cutaneous nerves in the limbs of man. Anat Rec. 1948;102:409–438.

100. Guttmamn L. Topographic studies of disturbances of sweat secretion after complete lesions of peripheral nerves. J Neurol Psychiatry.1940;3:197–210.

101. Richter CP, Woodruff PG. Lumbar dermatomes in man determined by electrical skin resistance method. J Electrophysiol. 1945;8:323–338.

102. Low PA, Stevens JC, Swarez GA, et al. Diseases of peripheral nerves. In: Joynt RJ, ed. Clinical Neurology. Philadelphia, PA: Lippincott-Raven; 1995:1–193.

103. Patten J. Neurological Differential Diagnosis. New York: Springer-Verlag; 1977.

104. Levin KH. Cervical radiculopathies: comparison of surgical and EMG localization of simple-root lesions. Neurology. 1996;46:1022–1025.

105. Warwick R, Williams PL. Gray’s Anatomy. 35th British edition. Philadelphia, PA: WB Saunders; 1973:994–1083.

106. Inman VT, Saunders JB. Referred pain from skeletal structures. J Nerv Mental Dis. 1944;99:660–667.

107. Dejerine J. Semiologie des affections du systeme nerveux. Paris: Masson & Cie; 1914.

108. Foerster O. Die Symptomatologie and Therapie der Kriegsverletzungen der Peripheren Nerven. Dtsch Z Nervenh. 1918;59:32–172.

109. Brash JC, ed. Cunningham’s Textbook of Anatomy. 9th ed. London: Oxford University Press; 1951.

110. Mitchell GAG. Anatomy of the Autonomic Nervous System. Edinburgh: Worthingstone; 1953.

111. Sheehan D. Discovery of the Autonomic Nervous System. Arch Neurol Psychiatry. 1936;35:1081–1115.

112. Johnson RH, Lambie DG, Spalding JMK. The autonomic nervous system. In: Joynt RJ, ed. Clinical Neurology. Philadelphia, PA: Lippincott-Raven; 1986:1–94.

113. World Health Organization. International Classification of Functioning, Disability and Health. ICF, Geneva: WHO; 2001.

114. Cieza A, Stucki G, Weigl M, et al. ICF Core Sets for chronic widespread pain. J Rehabil Med. 2004;(suppl 44):63–68.

115. Cieza A, Stucki G, Weigl M, et al. ICF core sets for low back pain. J Rehabil Med. 2004;(suppl 44):69–74.

116. Stucki G, Kostanjsek N, Üstün B, et al. ICF-based classification and measurement of functioning. Eur J Phys Rehab Med. 2008;44(3): 315–328.

117. Rauch A, Cieza A, Stucki G. How to apply the International Classification of Functioning, Disability and Health (ICF) for rehabilitation management in clinical practice. Eur J Phys Rehab Med.2008;44(3):329–342.

118. Cieza A, Stucki G. Applying the ICF and ICF Core Sets for chronic widespread pain. In: Wittink H, Carr D, eds. Pain Management: Evidence, Outcomes, and Quality of Life. A Sourcebook. Pain Research and Clinical Management Series. Edinburgh: Elsevier Limited; 2008: 161–170.

119. Frymoyer JW, Newberg A, Pope MH. Spine radiographs in patient with low back pain. J Bone Joint Surg Am. 1984;66:1048–1055.

120. Horal J. The clinical appearance of low back disorders in the city of Gothenburg, Sweden. Acta Orthop Scand Suppl. 1969;118:8–73.

121. Bigos SJ, Bowyer OR, Braen GR, et al. Acute Low Back Problems in Adults. Clinical Practice Guideline Number 14. Rockville, MD: U.S. Department of Health and Human Services; 1994.

122. Scavone JG, Latshaw RF, Rohrer GV. The use of lumbar spine films/statistical evaluation at a university teaching hospital. JAMA.1981;246:1105–1108.

123. Spangfort E. The lumbar disk herniation—a computer aided analysis of 2,504 operations. Acta Orthop Scand. 1972;142:1–95.

124. Hitselberger WE, Witten RM. Abnormal myelograms in asymptomatic patients. J Neurosurg. 1968;28:204–206.

125. Holt EP. The question of lumbar discography. J Bone Joint Surg Am.1968;50:720–726.

126. Wiesel SW, Tsourmas N, Feffer H. A study of computer assisted tomography—the incidence of positive CAT scans in an asymptomatic group of patients. Spine. 1984;9:549–551.

127. Jensen MC, Brant-Zawadzki MN, Abuchowski N, et al. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med. 1994;331:69–73.

128. Duckno PW, Margolis R, Tait RC. Psychological assessment in chronic pain. J Clin Psychol. 1985;41:499–504.

129. Turk DC, Melzack R. The measurement of pain and the assessment of people experiencing pain. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. 2nd ed. New York: Guilford Press; 2001:3–11.

130. Chapman CR, Casey KL, Dubner R, et al. Pain measurement: an overview. Pain. 1985;22:1–31.

131. Costello RM, Hulsey TL, Schoenfeld LS, et al. P-A-I-N: a four cluster MMPI typology for chronic pain. Pain. 1987;30:199–209.

132. Russo MR, Brooks FAR, Fontenot JP, et al. Sodium pentothal hypnosis: a procedure for evaluating medical patients with suspected psychiatric co-morbidity. Mil Med. 1997;162:215.

133. Simon EP, Dahl LF. The sodium pentothal hypnosis interview with follow-up treatment for complex regional pain syndrome. J Pain Symptom Manage. 1999;18:132.

134. Ellis JS, Schoenfeld LS, Ramamurthy S. Nonsomatic pain. Phys Med Rehabil Stars. 1991;5:103–132.

135. Shoichet R. Sodium amytal in the diagnosis of chronic pain. Can Psychiatr J. 1978;23:219–228.

136. Schoichet RR. Sodium amytal in the diagnosis of chronic pain. Can Psychiatr Assoc J. 1978,23:219.

137. Ramamurthy S, Rogers JN. Decision Making in Pain Management. St. Louis: BC Decker; 1993.

138. Dumitru D, Zwartz MJ, Amato AA. Electrodiagnostic Medicine. 2nd ed. Philadelphia, PA: Hanley & Belfus; 2001.

139. Dumitru D. Electrophysiologic evaluation of the pain patient. Phys Med Rehabil Stars. 1991;5:187–208.

140. Breivik H. Local anaesthetic blocks and epidurals. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack’s Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2006:507–519.

141. Winnie AP, Candido KD. Differential neural blockade in the diagnosis of pain mechanisms. In: Raj PP, ed. Practical Management of Pain.3rd ed. St. Louis: Mosby; 2000:427–438.

142. Ramamurthy S, Winnie AR. Diagnostic maneuvers in painful syndromes. In: Stein JM, Warfield CA, eds. International Anesthesiology Clinics, Pain Management. Boston: Little, Brown; 1983:47–50.

143. Loeser JD. Multidisciplinary pain programs. In: Loeser JD, ed. Bonica’s Management of Pain. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001:255–264.

144. King JC, Kelleher WJ. The chronic pain syndrome: the in-patient interdisciplinary rehabilitative behavioral modification approach. Phys Med Rehabil Stars. 1991;5:165–186.

145. Karjalainen K, Malmivaara A, van Tulder MW, et al. Multidisciplinary biopsychosocial rehabilitation for subacute low-back pain among working age adults. Cochrane Database Syst Rev. 2003;(2):CD002193. doi: 10.1002/14651858.CD002193.

146. Schonstein E, Kenny DT, Keating J, et al. Work conditioning, work hardening and functional restoration for workers with back and neck pain. Cochrane Database Syst Rev. 2003;(3):CD001822. doi: 10.1002/14651858.CD001822.

147. Karjalainen K, Malmivaara A, van Tulder M, et al. Biopsychosocial rehabilitation for upper limb repetitive strain injuries in working age adults. Cochrane Database Syst Rev. 2000;(3):CD002269. doi:10.1002/14651858.CD002269.

148. Grabois M. Pain clinics—role in the rehabilitation of patients with chronic pain. Ann Acad Med. 1983;12:428–433.

149. Loeser JD, Turk DC. Multidisciplinary pain management. In: Loeser JD, ed. Bonica’s Management of Pain. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001:2069–2079.

150. Deardorff WW, Rubin HS, Scott DW. Comprehensive multidisciplinary treatment of chronic pain: a follow-up study of treated and non-treated groups. Pain. 1991;45:35–43.

151. Kames LD, Rapkin AJ, Naliboff BD, et al. Effectiveness of interdisciplinary pain management program for the treatment of chronic pelvic pain. Pain. 1990;41:41–46.

152. Chapman SL, Brena SF, Bradford LA. Treatment outcome in a chronic pain rehabilitation program. Pain. 1981;11:255–268.

153. Maruta T, Swanson DW, McHardy MJ. Three-year follow-up of patients with chronic pain and treated in multi-disciplinary pain management center. Pain. 1990;41:47–53.

154. Peters JL, Large RG. A randomized control trial evaluating in- and outpatient pain control programs. Pain. 1990;41:283–293.

155. Bendix AF, Bendix T, Lund C, et al. Comparison of three intensive programs for chronic low back pain patients: a perspective randomized observer blinded study with one year follow-up. Scand J Rehabil Med Suppl. 1997;29:81–89.

156. Maruta T, Malinchoc M, Offord KP, et al. Status of patients with chronic pain thirteen years after treatment in a pain management center. Pain. 1988;74:199–204.

157. Tunks E, Crook J. Persistent pain. In: Basmajian JV, Banerjee SN, eds. Clinical Decision Making in Rehabilitation. New York: Churchill- Livingstone; 1996:93–118.

158. Carroll D, Moore RA, McQuay HJ, et al. Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database Syst Rev. 2000;(4):CD003222. doi: 10.1002/14651858.CD003222.

159. Trinh KV, Graham N, Gross AR, et al. Cervical Overview Group. Acupuncture for neck disorders. Cochrane Database Syst Rev.2006;(3):CD004870. doi: 10.1002/14651858.CD004870.pub3.

160. Furlan AD, van Tulder MW, Cherkin DC, et al. Acupuncture and dry-needling for low back pain. Cochrane Database Syst Rev.2005;(1):CD001351. doi: 10.1002/14651858.CD001351.pub2.

161. Yousefi-Nooraie R, Schonstein E, Heidari K, et al. Low level laser therapy for nonspecific low-back pain. Cochrane Database Syst Rev.2008;(2):CD005107. doi: 10.1002/14651858.CD005107.pub4.

162. Eldred E, Lindsley DF, Buchwald JS. The effect of cooling on mammalian muscle spindles. Exp Neurol. 1960;2:144–157.

163. Ottoson D. The effects of temperature on the isolated muscle spindle. J Physiol. 1965;180:636–648.

164. Fischer E, Solomon S. Physiological responses to heat and cold. In: Licht S, ed. Therapeutic Heat and Cold. 2nd ed. Baltimore: Waverly; 1965:126–169.

165. Kendall HO, Kendall FP, Boynton DA. Posture and Pain. New York: Robert E Krieger; 1952.

166. Johanson F, Remvig L, Kryger P, et al. Exercise for chronic low back pain. J Orthop Sports Phys Ther. 1995;22:52–59.

167. van Tulder MW, Koes BW, Bouter LM. Conservative treatment of acute and chronic non-specific low back pain: a systematic review of randomized control trials of the most common interventions. Spine.1997;22:2128–2156.

168. Faas A. Exercises: Which ones are worth trying, for which patients, and when? Spine. 1996;21:2874–2879.

169. Abenhaim, Rossignol M, Valat JP, et al. The role of activity in therapeutic management of back pain: report of the international Paris task force on back pain. Spine. 2000;25:1S–33S.

170. Mennell JM. The therapeutic use of cold. JAMA. 1975;74:1146–1157.

171. Swenson C, Sward L, Karlsson J. Cryotherapy in sports medicine. Scand J Med Sci Sports. 1996;6(4):193–200.

172. Nicholos JA, Hershman EB. The Lower Extremity and Spine in Sports Medicine. St. Louis: CV Mosby; 1986.

173. Lehmann JF, DeLateur RJ. Therapeutic Heat and Cold. 4th ed. Baltimore: Williams & Wilkins, 1990.

174. Grant AE. Massage with ice in the treatment of painful conditions of the musculoskeletal system. Arch Phys Med Rehabil. 1964;45: 233–238.

175. Pegg SMG, Littler TR, Littler EN. A trial of ice therapy and exercise in chronic arthritis. Physiotherapy. 1969;55:51–56.

176. Landen BR. Heat or cold for the relief of low back pain? Phys Ther.1967;47:1126–1128.

177. French SD, Cameron M, Walker BF, et al. Superficial heat or cold for low back pain. Cochrane Database Syst Rev. 2006;(1):CD004750. doi: 10.1002/14651858.CD004750.pub2.

178. Travell J. Ethyl chloride spray for painful muscle spasm. Arch Phys Med Rehabil. 1952;33:291–298.

179. Simons DG, Travell JG, Simms LS. Myofascial Pain and Dysfunction— The Trigger Point Manual. Upper Half of the Body Extremities. 2nd ed. Vol 1. Baltimore: Williams & Wilkins; 1998.

180. Travell JG, Simons DG. Myofascial Pain and Dysfunction—The Trigger Point Manual. The Lower Extremities. Vol 2. Baltimore: Williams & Wilkins; 1992.

181. Mense S. Effects of temperature on the discharge of muscle spindles and tendon organs. Pflugers Arch. 1978;375:159–166.

182. Nadler SF, Steiner DJ, Hengehold HA, et al. Continuous low level heat wrap therapy provides more efficacy than ibuprofen and acetaminophen for acute low back pain. Spine. 2002;27(10):1012–1017.

183. Kottke FJ, Pauley DL, Rudolph PA. The rational for prolonged stretching for correction of shortening of connective tissue. Arch Phys Med Rehabil. 1966;47:345–352.

184. Taub A, Kane K. A history of local analgesia. Pain. 1975;1:125–138.

185. Brosseau L, Milne S, Robinson V, et al. Efficacy of the transcutaneous electrical nerve stimulation for the treatment of chronic low back pain: a meta-analysis. Spine. 2002;27(6):596–603.

186. Khadilkar A, Odebiyi DO, Brosseau L, et al. Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain. Cochrane Database Syst Rev. 2008;8(4):CD003008.

187. Banerjee SN. Nonsurgical treatment of acute low back pain. In: Basmajian JV, Banerjee SN, eds. Clinical Decision Making in Rehabilitation. New York: Churchill-Livingstone; 1996:6892.

188. Canthen JC, Renner EJ. Transcutaneous and peripheral nerve for chronic pain states. Surg Neural. 1975;11:102–104.

189. Meyer GA, Fields HL. Causalgia treated by selective large fiber stimulation of peripheral nerve. Brain. 1972;95:163–168.

190. Hansson P, Lundeberg T. Transcutaneous electrical nerve stimulation and acupuncture. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack’s Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2006:583–590.

191. Melzack R, Stillwell DM, Fox EJ. Trigger points and acupuncture points for pain: correlations and implications. Pain. 1977;3:3–23.

192. Kotani N, Hashimoto H, Sato Y, et al. Preoperative intradermal acupuncture reduces postoperative pain, nausea, and vomiting, analgesic requirement, and sympathoadrenal responses. Anesthesiology.2001;95(2):349–356.

193. Carlsson CP, Sjolund BH. Acupuncture for chronic low back pain: a randomized placebo-controlled study with long-term follow-up. Clin J Pain. 2001;17(4):296–305.

194. Smith LA, Oldman AD, McQuay HJ, et al. Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain. Pain. 2000;86(1–2):119–132.

195. Furlan AD, van Tulder MW, Cherkin DC, et al. Acupuncture and dry-needling for low back pain. Cochrane Database Syst Rev.2005;(1):CD001351.

196. Wu WH, Akande AA. Alternative medicine for chronic pain: a critical review. In: Aronoff GM, ed. Evaluation and Treatment in Chronic Pain.3rd ed. Baltimore: Williams & Wilkins; 1998;627–641.

197. Mannion AF, Taimela S, Muntener M, et al. Active therapy for chronic low back pain, part I: effects on back muscle activation, fatigability, and strength. Spine. 2001;26(8):897–908. 198. Basmajian JV, Wolf SL. Therapeutic Exercise. 5th ed. Baltimore: Williams & Wilkins; 1990.

199. Kraus H. Therapeutic Exercise. 2nd ed. Springfield, IL: Charles C. Thomas; 1963.

200. van Tulder M, Koes B. Low back pain. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack’s Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2006:699–708.

201. Hayden JA, van Tulder MW, Malmivaara A, et al. Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev.2005;(3):CD000335. doi: 10.1002/14651858.CD000335.pub2.

202. Liddle SD, Baxter GD, Jacqueline HG. Exercise and chronic low back pain: what works? Pain. 2004;107:176–190.

203. Panjabi MM. The stabilizing system of the spine: Part 1. Function, dysfunction, adaptation, and enhancement. J Spinal Disord.1992;7:19–32.

204. Barr KP, Griggs M, Cadby T. Lumbar stabilization core concepts and current literature, part 1. Am J Phys Med Rehabil. 2005;85: 473–480.

205. Crisco JJaMMP. Euler stability of the human ligamentous lumbar spine. Clin Biomech. 1992;7:19–32.

206. Laasonen EM. Atrophy of the sacrospinal muscle groups in patients with chronic, diffusely radiating lumbar back pain. Neuroradiology.1984;26:9–13.

207. Hodges PW, Richardson CA. Inefficient muscular stabilization of the lumbar spine associated with low back pain; A motor control evaluation of the transversus abdominis. Spine. 2002;27:E29–E36.

208. Ferreira PH, Ferreira ML, Hoddges PW. Contraction of the pelvic floor muscles in patients with low back pain: ultrasound measurement of muscle activity. Spine. 2004;29:2560.

209. O’Sullivan PB, Phyty DM, Twomey LT, et al. Evaluation of specific stabilizing exercise in the treatment of chronic low back pain with radiologic diagnosis of spondyloysis or spondylololithesis. Spine.1997;22(24):2959–2967.

210. Cairns MC, Foster NE, Wright C. Randomized controlled trial of specific spinal stabilization exercises and conventional physiotherapy for recurrent low back pain. Spine. 2006; 31:E670–E681.

211. Assendelft WJJ, Morton SC, Yu Emily I, et al. Spinal manipulative therapy for low-back pain. Cochrane Database Syst Rev. 2004;(1):CD000447. doi: 10.1002/14651858.CD000447.pub2.

212. Gross AR, Hoving JL, Haines TA, et al. Manipulation and mobilization for mechanical neck disorders. Cochrane Database Syst Rev.2004;(1):CD004249. doi: 10.1002/14651858.CD004249.pub2.

213. Furlan AD, Brosseau L, Imamura M, et al. Massage for lowback pain. Cochrane Database Syst Rev. 2002;(2):CD001929. doi: 10.1002/14651858.CD001929.

214. Haraldsson BG, Gross AR, Myers CD, et al. Massage for mechanical neck disorders. Cochrane Database Syst Rev. 2006;(3):CD004871. doi: 10.1002/14651858.CD004871.pub3.

215. Rackwitz B, de Bie R, Limm H, et al. Segmental stabilizing exercises and low back pain. What is the evidence? A systematic review of randomized controlled trials. Clin Rehabil. 2006;20:553–567.

216. Fulton WM. Psychological strategies and techniques in pain management. Semin Anesth. 1985;4:247–254.

217. Malone MD, Strube MJ. Meta-analysis of non-medical treatments for chronic pain. Pain. 1988;34:231–244.

218. France R, Krishnau KRR, eds. Chronic Pain. Washington, DC: American Psychiatric Press; 1988.

219. Eimer BN, Freeman A. Pain Management Psychotherapy: A Practical Guide. New York: John Wiley and Sons; 1998.

220. Gatchel RJ, Turk DC, eds. Psychological Approaches to Pain Management: A Practitioner’s Guide. New York: The Guilford Press; 1996.

221. Miller L. Psychotherapeutic approaches to chronic pain. Psychotherapy.1993;30:115–123.

222. Heymans MW, van Tulder MW, Esmail R, et al. Back schools for nonspecific low-back pain. Cochrane Database Syst Rev. 2004;(4):CD000261. doi: 10.1002/14651858.CD000261.pub2.

222a. Roelofs PDDM, Deyo RA, Koes BW, et al. Non-steroidal antiinflammatory drugs for low back pain. Cochrane Database Syst Rev.2008;(1):CD000396. doi: 10.1002/14651858.CD000396.pub3.

223. Barber J, Adrian C, eds. Psychological Approaches to the Management of Pain. New York: Brunner/Mazel; 1982.

224. Chapman S. A review and clinical perspective on the use of EMG and thermal biofeedback for chronic headaches. Pain. 1986;27:1–43.

225. Flor H, Haag G, Turk D. Long-term efficacy of EMG biofeedback for chronic rheumatic back pain. Pain. 1986;27:195–202.

226. Fernandez E. A classification system of cognitive coping strategies for pain. Pain. 1986;26:141–151.

227. Edmonston W Jr. Hypnosis and Relaxation. New York: Wiley; 1981.

228. Smith J. Relaxation Dynamics. Chicago, IL: Research Press; 1985.

229. Barber J. Rapid induction analgesia: a clinical report. Am J Clin Hypn.1977;19(3):138–145.

230. Crasilneck HB, Hall JA. Clinical Hypnosis: Principles and Applications. Orlando: Grune & Stratton; 1985.

231. Eimer BN. Clinical applications of hypnosis for brief and efficient pain management psychotherapy. Am J Clin Hypn. 2000;43(1):17–40.

232. Montgomery GH, DuHamel KN, Redd WH. A meta-analysis of hypnotically induced analgesia: how effective is hypnosis? Int J Clin Exp Hypn. 48:138–153.

233. Oulltte EA. Pain management and medical hypnosis. AAOS Instructional Course Lectures. 2000;49:541–543.

234. Houde RW, Wallenstein SL, Beaver WT. Evaluation of analgesics in patients with cancer pain. In: Lasagna L, ed. International Encyclopedia of Pharmacology and Therapeutics. New York: Pergamon; 1966.

235. De Craen AJM, Di Giulio G, Lamp-Schoenmaeckers AJEM, et al. Analgesic efficacy and safety of paracetamol-codeine combination vs. paracetamol alone: a systematic review. Br Med J. 1996;313: 321–325.

236. McNicol E, Strassels SA, Goudas L, et al. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev. 2005;(2):CD005180. doi: 10.1002/14651858. CD005180.

237. Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2007;(4):CD003868. doi: 10.1002/14651858. CD003868.pub2.

238. Edwards JE, Oldman A, Smith L, et al. Single dose oral aspirin for acute pain. Cochrane Database Syst Rev. 1999;(4):CD002067. doi: 10.1002/14651858.CD002067.

239. Marks RW, Sacher EJ. Undertreatment of medical patients with opioid analgesia. Ann Intern Med. 1973;78:173–181.

240. Kanner RM, Foley KM. Patterns of opioid drug use in cancer pain clinic. Ann NY Acad Sci. 1981;362:161–172.

241. Foley KM. Changing concepts of tolerance to opioids: what the cancer patient has taught us? In: Chapman CR, Foley KM, eds. Current and Emerging Issues in Cancer Pain: Research and Practice. New York: Raven Press; 1993:331–350.

242. Deshpande A, Furlan A, Mailis-Gagnon A, et al. Opioids for chronic low-back pain. Cochrane Database Syst Rev. 2007;(3):CD004959. doi: 10.1002/14651858.CD004959.pub3.

243. Huber SL, Hill CS. Pharmacologic management of cancer pain. Cancer Bull. 1980;32:183–185.

244. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev. 2004;(3):CD004847. doi: 10.1002/14651858.CD004847.

245. Moertel CG. Relief of pain with oral medications. Aust NZ J Med.1976;6:1–8.

246. White PF. Patient-controlled analgesia: a new approach to the management of postoperative pain. Semin Anesth. 1985;4:255–266.

247. Ross FB, Smith MT. The intrinsic antinociceptive effects of oxycodone appear to be K-opioid receptor mediated. Pain. 1997;73:151–157.

248. Nielsen CK, Ross FB, Smith MT. Incomplete asymmetric and routedependent cross-tolerance between oxycodone and morphine in the dark agonti rot. J Pharmacol Exp Ther. 2000;295:91–99. 249. Manna V, Bolino F, De Cicco L. Chronic tension-type headache, mood depression, and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache. 1994;34:44–49.

250. Sindrup SH, Gram LF, Brosen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 1990;42:135–144.

251. Swerdlow M. Anticonvulsant drugs in chronic pain. Clin Neuropharmacol.1984;7:51–82.

252. Urquhart DM, Hoving JL, Assendelft WWJJ, et al. Antidepressants for non-specific low back pain. Cochrane Database Syst Rev.

2008;(1):CD001703. doi: 10.1002/14651858.CD001703.pub3.

253. Dworkin RH, O’Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidenced-based recommendations. Pain.2007;132:237–251.

254. Lunn MPT, Hughes RAC, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. (Protocol) Cochrane Database Syst Rev.2008;(2):CD007115. doi: 10.1002/14651858.CD007115.

255. Walsh PD. Antidepressants in chronic pain. Clin Neuropharmacol.1983;6:271–295.

256. Aronoff GM, Evans WO. Doxipam as an adjuvant in the treatment of chronic pain. J Clin Psychol. 1982;43:42–47.

257. McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain. 1997;68:217–228.

258. Anghena P, van Houdenkove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo controlled studies. Headache. 1994;34:44–49.

259. Wiffen P, Collins S, McQuay H, et al. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD001133. doi: 10.1002/14651858.CD001133.pub2.

260. Wiffen PJ, McQuay HJ, Edwards JE, et al. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD005452. doi: 10.1002/14651858.CD005452.

261. Wiffen PJ, McQuay HJ, Moore RA, et al. Carbamezipine for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD005451. doi: 10.1002/14651858.CD005451.

262. Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev. 2007;(2):CD006044. doi: 10.1002/14651858. CD006044.pub2.

263. McNamara JO. Pharmacotherapy of the epilepsies. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw-Hill; 2006:501–525.

264. Moshe SL. Mechanisms of action of anti-convulsant agents. Neurology.2000;55:S32–S40.

265. Bergey GK. Future of anti-epileptic drug development. Neurology.2000;55:S47–S53.

266. Dellocchio C, Buffa C, Mazzarello P, et al. Gabapentine vs. amitriptyline in painful diabetic neuropathy: an open label pilot study. J Pain Symptom Manage. 2000;20:280–285.

267. Roubotham M, Hardin N, Stacey B, et al. Gabapentine for the treatment of post-herpetic neuralgia: a randomized controlled trial. JAMA.1998;280:1837–1842.

268. Ramamurthy S, Winnie AP. Regional anesthetic techniques for pain relief. Semin Anesth. 1985;4:237–245.

269. Raferty A. The management of postherpetic pain using sodium valproate and amitriptyline. Ir Med J. 1979;72:399–401.

270. Watson CPN, Vernich L, Chipman M, et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology.1998;51:1166–1171.

271. Basmajian JV. Cyclobenzaprine hydrochloride effects on musculoskeletal spasm in the lumbar spine region and neck: two double-blind controlled clinical and laboratory studies. Arch Phys Med Rehabil.1978;59:58–63.

272. Greenblatt JD, Shader RI, Abernathy DR. Current status of benzodiazepines. N Engl J Med. 1983;309:410–416.

273. Dellemijn PLI, Fields HL. Clinical review: do benzodiazepines have a role in chronic pain management? Pain. 1994;57:137–152.

274. Lippman RS. Pharmacotherapy of anxiety and depression. Psychopharmocol Bull. 1981;171:91–103.

275. van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for nonspecific low-back pain. Cochrane Database Syst Rev. 2003;(4):CD004252. doi: 10.1002/14651858.CD004252.

276. Savage S, Covington EC, Heit HA, et al. Definitions related to the use of opioids for the treatment of pain: consensus documents from The American Academy of Pain Medicine, The American Pain Society, and The American Society of Addiction Medicine, 2001. Available at: http:// www.ampainsoc.org; http://www.painmed.org; http://www.asam.org.

277. Rowlingson JC, Chalkley J. Common pain syndromes—diagnosis and management. Semin Anesth. 1985;4:223–230.

278. Walsh NE, Ramamurthy S. Neck and upper extremity pain. In: Raj PP, ed. Practical Management of Pain. 2nd ed. Chicago: Year Book Medical; 1992:272–295.

279. Deyo RA. Clinical research methods in low back pain. Phys Med Rehabil Stars. 1991;5:209–222.

280. Deyo RA. Measuring the functional status of patients with low back pain. Arch Phys Med Rehabil. 1988;69:1044–1053.

281. Turk DC, Rudy TE. Neglected factors in chronic pain treatment outcome studies—referral patterns, failure to enter treatment, and attrition. Pain. 1990;43:7–25.

282. Bonica JJ. Management of myofascial pain syndromes in general practice. JAMA. 1957;164:732–738.

282. Turk DC, Dworkin RH, Burke LB, et al. Initiative on methods, measurement and pain assessment in clinical trials. Developing patientreported outcome measures for pain clinical trials: IMMPACT recommendations. Pain. 2006;125:208–215.

283. Gunn CC, Milbrandt WE, Little AS, et al. Dry needling of muscle motor points for chronic low back pain. Spine. 1980;5:279–290.

283. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;123:9–19.

284. Kraus H. Triggerpoints. NY State J Med. 1973;73:1310–1314.

285. Ready LB, Kozody R, Barsa JE, et al. Trigger point injections versus jet injection in the treatment of myofascial pain. Pain. 1983;15:201–206.

286. Sola AE, Bonica JJ. Myofascial pain syndromes. In: Loeser JD, ed. Bonica’s Management of Pain. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001:530–542.

287. Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil. 2001;82:986–997.

288. Cheshire WP, Abashian SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain. 1994;59:65–69.

289. Porta M. A comparative trial of botulinum toxin A and methoprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasms. Pain. 2000;85:101–105.

290. Verhagen AP, Karels C, Bierma-Zeinstra SMA, et al. Ergonomic and physiotherapeutic interventions for treating work-related complaints of the arm, neck or shoulder in adults. Cochrane Database Syst Rev.2006;(3):CD003471. doi: 10.1002/14651858.CD003471.pub3.

291. Baron R. Clinical neuropathic pain: from mechanisms to symptoms. Clin J Pain. 2000;16:S12–S20.

292. Gold MS, Chessell I, Devor M, et al. Peripheral nervous system targets: rapporteur report. In: Campbell JN, Bausbaum AI, Dray A, et al., eds. Emerging Strategies for the Treatment of Neuropathic Pain. Seattle: IASP Press; 2006:3–36.

293. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454. doi: 10.1002/14651858. CD005454.pub2.

294. Challapalli V, Tremont-Lukats IW, McNicol ED, et al. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev. 2005;(4):CD003345. doi: 10.1002/14651858. CD003345.pub2.

295. Tremont-Lukata IW, Megeff C, Backonja MN. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs. 2001;60:1029–1052.

296. Dumitru D, Gershkoff AM, Walsh NE. Peripheral nervous and muscular system. In: Felsenthal G, Garrison SJ, Steinberg FU, eds. Rehabilitation of the Aging and Elderly Patient. Baltimore: Williams & Wilkins; 1994:227–242.

297. Pernia A, Mico JA, Calderon E, et al. Fluoxetine for treatment of neuropathic pain. J Pain Symptom Manage. 2000;19:408–410.

298. Harden RN, Bruehl SP. Diagnostic criteria: the statistical derivation of the four criterion factors. In: Wilson PR, Stanton-Hicks M, Harden RN, eds. CRPS: Current Diagnosis and Therapy. Seattle: ISAP Press; 2005:45–58.

299. Verdugo RJ, Ochoa JL. Sympathetically maintained pain: I. Plentolamine block questions the concept. Neurology. 1994;44:1003– 1010.

300. Dumitru D. Reflex sympathetic dystrophy. Phys Med Rehabil Stars.1991;5:89–102.

301. Baron R. Complex regional pain syndromes. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack’s Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2006:1011–1027.

302. Ghostine SY, Comair YG, Turner DM, et al. Phenoxybenzamine in the treatment of causalgia: report of 40 cases. J Neurosurg. 1984;60: 1263–1268.

303. Cepeda MS, Carr DB, Lau J. Local anesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev.2005;(4):CD004598. doi: 10.1002/14651858.CD004598.pub2.

304. Lewis R Jr, Racz G, Fabian G. Therapeutic approaches to reflex sympathetic dystrophy of the upper extremity. Clin Iss Reg Anesth.1985;1:1–6.

305. Ford SR, Forrest WH, Eltherington L. Treatment of reflex sympathetic dystrophy with intravenous regional bretylium. Anesthesiology.1988;68:137–140.

306. Ramamurthy S, Hoffman J, et al. Intravenous regional guanethidine in the treatment of reflex sympathetic dystrophy and causalgia: a randomized, double-blind study. Anesth Analg. 1995;81:718–723.

307. Jadad AR, Carroll D, Glynn CJ, et al. Intravenous regional sympathetic blockade for pain relief in reflex sympathetic dystrophy: a systematic review and a randomized, double-blind crossover study. J Pain Symptom Manage. 1995;10:13–20.

308. North RB, Long DM. Spinal cord stimulation for intractable pain: eight year followup. Pain. 1994;59(suppl 2):79.

309. Novak CB, Mackinnon SE. Outcome following implantation of a peripheral nerve stimulator in patients with chronic nerve pain. Plast Reconstr Surg. 2000;105:1967–1972.

310. Covar B, Rosenfeld JV, Hutchinson A. The efficacy of spinal cord stimulation for chronic pain. J Clin Neurosci. 2000;7:409–413.

311. Oerlemnans HM, Oostendorp RA, de Boo T, et al. Pain and reduced mobility in the complex regional pain syndrome I: outcome of a perspective randomized controlled clinical trial of adjuvant physical therapy vs. occupational therapy. Pain. 1999;83:77–83.

312. Galer BS, Dworkin RH, eds. A Clinical Guide to Neuropathic Pain. Minneapolis: McGraw Hill Health Care Information; 2000.

313. Jensen TS, Krebs B, Nielsen J, et al. Immediate and long term phantom limb pain in amputees—incidence, clinical characteristics, and relationship to preamputation limb pain. Pain. 1985;21:267–278.

314. Sherman RA, Sherman CJ. Prevalence and characteristics of chronic phantom limb pain among American veterans. Am J Phys Med.1983;62:227–238.

315. Kalauokalani DAK, Loeser JD. Phantom limb pain. In: Crombie IK, ed. Epidemiology of Pain. IASP Press: Seattle; 1999:143–53.

316. Nikolajsen L, Jensen TS. Phantom limb pain. Br J Anaesth. 2001;87: 107–116.

317. Jensen TS, Krebs B, Nielson J, et al. Phantom limb, phantom pain, and stump pain in amputees during the first months following limb amputation. Pain. 1983;17:243–256.

318. Ehde Czerniecki, Smith, et al. Chronic phantom limb sensations, phantom limb pain, residual limb pain, and other regional pain after lower limb amputation. Arch Phys Med Rehabil. 2000;81:1039–1045.

319. Sherman RA. Phantom Pain. New York: Plenum Press; 1997.

320. Nikolajsen L, Ilkjaer S, Christensen JH, et al. Randomized trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in lower-limb amputation. Lancet. 1997;350:1353–1357.

321. Banerjee SN. Lower extremity amputations. In: Basmajian JO, Banerjee SN, eds. Clinical Decision Making in Rehabilitation. New York: Churchill-Livingstone; 1996:153–170.

322. Sherman R, Sherman C, Gall N. A survey of current phantom limb treatment in the United States. Pain. 1980;8:85–99.

323. Sherman RA. Postamputation pain. In: Jensen TS, Wilson PR, Rice ASC, eds. Clinical Pain Management: Chronic Pain. London: Arnold Press; 2003:239–249.

324. Flor H. Phantom-limb pain: phantom-limb pain: characteristics, causes, and treatment. Lancet Neurol. 2002;1:182–189.

325. Alviar MJM, Dungca M. Pharmacotherapeutic interventions for treating phantom limb pain. Cochrane Database Syst Rev. 2007;(1):CD006380. doi: 10.1002/14651858.CD006380.

326. Ramachandran VS, Rogers-Ramachandran D. Synaesthesia in phantom limbs included with mirrors. Biol Sci. 1996;263:377–86.

327. Nikolajsen L, Hansen CL, Nielsen J, et. al. The effect of ketamine on phantom limb pain: a central neuropathic disorder maintained by peripheral input. Pain. 1996;67:69–77.

328. Flor H, Elbeert T, Knecht S, et al. Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation. Nature.1995;375:482–484.

329. Ramamurthy S, Walsh NE, Schoenfeld LS, et al. Evaluation of neurolytic blocks using phenol and cryogenic block in the management of chronic pain. J Pain Symptom Manage. 1989;4:72–75.

330. Cleeland C. The impact of pain on the patient with cancer. Cancer.1984;54:2635–2641.

331. McGivney WT, Crooks GM. The case of patients with severe chronic pain in terminal illness. JAMA. 1984;251:1182–1188.

332. Black P. Management of cancer pain—an overview. Neurosurgery.1979;5:507–518.

333. Jacox A, Carr DB, Payne R, et al. Management of Cancer Pain. Clinical Practice Guideline No. 9, AHCPR Publication No. 94-0592. Rockville, MD: Agency for Health Care Policy and Research, US Department of Health and Human Services, Public Health Service; 1994.

334. Cancer Pain Relief and Palliative Care: Report of a WHO Expert Committee. Technical Report Series No. 804. Geneva, Switzerland: World Health Organization; 1990.

335. World Health Organization. Cancer pain relief: with a guide to opioid availability, 2nd ed. Geneva, Switzerland: World Health Organization; 1996.

336. Jacox A, Carr D, Payne R, et al. Management of Cancer Pain: Clinical Practice Guidelines, No. 9. AHCPR 94-0592, Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service; March 1994.

337. Cousins J, Mather L. Intrathecal and epidural administration of opiates. Anesthesiology. 1984;61:276–310.

338. Eisenach J, Rauck R, Buzzanell C, et al. Epidural clonidine analgesia for intractable cancer pain: phase I. Anesthesiology. 1989;71:647–652.

339. Freidberg SR. Neurosurgical treatment of pain caused by cancer. Med Clin North Am. 1975;59:481–485.

340. Epstein E. Intralesional triamcinolone therapy in herpes zoster and post herpetic neuralgia. Ear Nose Throat Mon. 1973;52:416.

341. Bennet GJ. Hypothesis on the pathogenesis of herpes zoster-associated pain. Ann Neurol. 1994;35:S38–S41.

342. Periquet MI, Novak V, Collins MP, et al. Painful sensory neuropathy: perspective evaluation using skin biopsy. Neurology. 1999;53: 1641–1647.

343. Holland NR, Stocks A, Hauer P, et al. Intra-epidermal nerve fiber density in patients with painful sensory neuropathy. Neurology.1997;48:708–711.

344. Oaklander AL. The density of remaining nerve endings in human skin with and without post-herpetic neuralgia after shingles. Pain.2001;92:139–145.

345. Rowbotham MC, Fields HL. Topical lidocaine reduces pain in postherpetic neuralgia. Pain. 1989;38:297–302. 346. Rowbotham MC, Davies PC, Verkempinck C, et al. Lidocaine patch— blind controlled study of a new treatment method for post-hepatic neuralgia. Pain. 1996;65:39–44.

347. Khaliq W, Alam S, Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2007;(2): CD004846. doi: 10.1002/14651858.CD004846.pub2.

348. Siddall PJ, Loeser JD. Pain following spinal cord injury. Spinal Cord.2001;39:63–73.

349. Siddall PJ, Loeser JD. Pain following spinal cord injury: clinical features, prevalence, and taxonomy. Spinal Cord. 2000;39:63–73.

350. Boivie J. Central pain. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack’s Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2006:1057–1074.

351. Wittink H, Michel TH. Physical therapy: evaluation and treatments of chronic pain patients. In: Aronoff GM, ed. Evaluation and Treatment of Chronic Pain. 3rd ed. Baltimore: Williams & Wilkins, 1998: 565–573.

352. Young PA. The anatomy of the spinal cord pain paths—a review. J Am Paraplegia Soc. 1986;9:28–38.

353. Lamid S, Chia JK, Kohli A, et al. Chronic pain in spinal cord injury: comparison between inpatients and outpatients. Arch Phys Med Rehabil.1985;66:777–778.

354. Brice TN, Regnorson KT. Pain after spinal cord injury. Phys Med Rehabil Clin N Am. 2000;11:157–168.

355. Kennedy P, Frankel H, Gardner B, et al. Factors associated with acute and chronic pain following traumatic spinal cord injuries. Spinal Cord.1997;35:814–817.

356. New PW, Lim TC, Hill ST, et al. A survey of pain during rehabilitation after acute spinal cord injury. Spinal Cord. 1997;35:658–663.

357. Siddall TJ, Taylor DA, McClelland JM, et al. Pain report and relationship of pain to physical factors in the first six months following spinal cord injury. Pain. 1999;81:187–197.

358. Stormer S, Gerner HJ, Groeninger W, et al. Chronic pain/dysaesthesia in spinal cord injury patients: result of a multicentre study. Spinal Cord.1997;35:446–455.

359. Nepomuceno C, Fine PR, Richards JS, et al. Pain in patients with spinal cord injury. Arch Phys Med Rehabil. 1979;60:605–609.

360. Bonica JJ. Introduction: semantic epidemiologic and educational issues. In Casey KL, ed. Pain in Central Nervous System Disease: The Central Pain Syndromes. New York: Raven Press; 1991:13–29.

361. Britell CW, Mariano AJ. Chronic pain in spinal cord injury. Physical Medicine and Rehabilitation: State of the Art Reviews. 1991;5:71–82.

362. Siddall PJ. Pain following spinal cord injury. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack’s Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2006:1043–1055.

363. Yezierki RP. Pain following spinal cord injury: the clinical problem and experimental studies. Pain. 1997;68:185–194.

364. Farkash AE, Portenoy RK. The pharmacological management of chronic pain in the paraplegic patient. J Am Paraplegia Soc. 1986;9:41–50.

365. Britell CW, Mariano AJ. Chronic pain in spinal cord injury. Phys Med Rehabil Stars. 1991;5:71–82.

366. Hachen HA. Psychological, neuropsychological, and therapeutic aspects of chronic pain—preliminary results with transcutaneous electrical stimulation. Paraplegia. 1977;15:357–367.

367. Kassirer MR. Osterberger DH. Pain and chronic multiple sclerosis. J Pain Symptom Manage. 1987;2:95–97.

368. Osterberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis. Eur J Pain. 2005;9:531–542.

369. Svendsen KB, Jensen TS, Overvad K, et al. Pain in patients with multiple sclerosis: a population-based study. Arch Neurol. 2003;60: 1089–1094.

370. Kassirer MR, Osterberger DH. Pain and chronic multiple sclerosis. J Pain Symptom Manage. 1987;2:95–97.

371. Houtchens MK, Richert JR, Sami A, et al. Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler. 1997;3:250–253.

372. Martin JJ. Thalamic syndromes. In: Vinken PJ, Bruyne GW, eds. Handbook of Clinical Neurology. Vol 2. Localization in Clinical Neurology. Amsterdam: North Holland Publishing; 1962:469–496.

373. Stanton-Hicks M, Abram SE, Nolte H. Sympathetic blocks. In: Raj PP, ed. Practical Management of Pain. Chicago: Year Book Medical; 1986:661–681.

374. Garrison SJ. Post-stroke pain. Phys Med Rehabil Stars. 1991;5:83–88.

375. Leijon G, Boivie J. Central post-stroke pain—the effect of high and low frequency TENS. Pain. 1989;38:187–191.

376. Liguori R, Krurup C, Joberg T, et al. Determining the segmental sensory and motor innervation of the lumbosacral spinal nerve. Brain.1992;115:915–944.

377. Sindow M, Mifsud JJ, Boisson D, et al. Selected posterior rhizotomy in the dorsal route entry zone for treatment of hyper-spasticity in pain in the hemiplegic upper limb. Neurosurgery. 1986;18:587–595.

378. Tasker RR. Central pain states. In: Loeser JD, ed. Bonica’s Management of Pain. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001:433–457.

379. Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum.1995;38:19–28.

380. Lawrence RC, Hemlock CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778–799.

381. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990; 33(2):160–172.

382. Endresen GK, Fibromyalgia: a rheumatologic diagnosis? Rheum Int.2007;27:999–1004.

383. Nishishinya B, Walitt B, Urrutia G, et al. Anti-depressants and centrally active agents for fibromyalgia syndrome. (Protocol) Cochrane Database Syst Rev. 2006;(4):CD006192. doi: 10.1002/14651858.CD006192.

384. Staud R, Cannon RC, Mauderli AP, et al. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain. 2003;102:87–95.

385. Martinez-Lavin M. Overlap of fibromyalgia with other medical conditions. Curr Pain Headache Rep. 2001;5:347–350.

386. Staud R. Fibromyalgia pain: do we know the source? Curr Opin Rheumatol. 2004;16:157.

387. Buskila D. Genetic of chronic pain states. Best Pract Res Clin Rheumatol.2007;21:535–547.

388. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264–1273.

389. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics. 2000;41: 104–113.

390. Arnold LM, Pritchett YL, D’ Souza DN, et al. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials. J Women’s Health. 2007;16: 1145–1156.

391. Mease PJ. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheum. 2005;75:6–21.

392. Ferr-Garcia MD, Wernicke JF, Detke MJ, et al. The depression-pain complex: overlap between two problems and implications for neuropathic pain. In: Campbell JN, Basbaum AI, Dray A, et al., eds. Emerging Strategies for the Treatment of Neuropathic Pain. Seattle: IASP Press; 2006:307–325.

393. Bennett RM, Kamin M, Karim R, et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a doubleblind, randomized, placebo controlled study. Am J Med. 2003;114: 537–545.

394. Goldenberg DL, Burkhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292:2388–2395.

395. Busch AJ, Barber KAR, Overend TJ, et al. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2007;(4):CD003786. doi: 10.1002/14651858.CD003786.pub2.

396. Arnold LM. Biology and therapy of fibromyalgia: new therapies in fibromyalgia. Arthritis Res Ther. 2006;8:212–17. 397. Karjalainen K, Malmivaara A, van Tulder M, et al. Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev. 1999;(3):CD001984. doi: 10.1002/14651858.CD001984.

398. Andersson GBJ, Pope MH, Frymoyer JW, et al. Epidemiology and cost. In: Pope MH, Andersson GBJ, Frymoyer JW, et al., eds. Occupational Low Back Pain: Assessment, Treatment, and Prevention. St. Louis: CV Mosby; 1991:95–113.

399. Biggos SJ, Spengler DM, Martin NA, et al. Back injuries in industry: a retrospective study. III. Employee-related factors. Spine. 1986;11: 252–256.

400. Borenstein DG, Wiesel SW. Low Back Pain: Medical Diagnosis and Comprehensive Management. Philadelphia, PA: WB Saunders; 1989.

401. Scheer SJ, Radack KL, O’Brien DR. Randomized controlled trials in industrial low back pain. Part I. Acute interventions. Arch Phys Med Rehabil. 1995;76:966–973.

402. Scheer SJ, Radack KL, O’Brien DR. Randomized controlled trials in industrial low back pain relating to return to work. Part II. Discogenic back pain. Arch Phys Med Rehabil. 1996;77:1189–1197.

403. Scheer SJ, Radack KL, O’Brien DR. Randomized controlled trials in industrial low back pain. Part III. Subacute/chronic pain interventions. Arch Phy Med Rehabil. 1997;78:414–423.